Is CureVac NV CVAC stock halal to invest in?

No, as of February 2026, CureVac NV stock (CVAC) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. CureVac NV has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for CureVac NV and alternative halal stock options within the Tabadulat app.

How often is CureVac NV CVAC reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on CureVac NV CVAC monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does CureVac NV CVAC pass the AAOIFI Non Permissible Income criteria?

Yes, as of February 2026, CureVac NV stock (CVAC) passes the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources, such as interest, is below the acceptable threshold set by AAOIFI.

Does CureVac NV CVAC pass the AAOIFI Interest Bearing Investments criteria?

No, as of February 2026, CureVac NV stock (CVAC) does not pass the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments have exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of February 2026, CureVac NV stock (CVAC) passes the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt is below the acceptable threshold set by AAOIFI.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

CureVac NV

NASDAQ

Shariah-Compliant

Not Shariah

CVAC

About

CureVac NV

CVAC

CureVac N.V. is a biotechnology company that specializes in developing transformative medicines based on messenger ribonucleic acid (mRNA). Established in 2000 and headquartered in Tübingen, Germany, the company focuses on the creation of vaccines and therapeutics targeting infectious diseases, oncology, and rarer genetic disorders. CureVac leverages its proprietary technology platform to harness the full potential of mRNA as a data carrier, allowing cells to produce proteins that can fight a variety of health challenges. A notable aspect of CureVac's work is its contribution to vaccine development, particularly during global health crises like the COVID-19 pandemic, where mRNA-based solutions have gained significant prominence. The company's approach has implications across several sectors, including healthcare, pharmaceuticals, and biotechnology, highlighting its multifaceted role in advancing medical science and vaccine technology. In the financial markets, CureVac's significance is underscored by its ongoing clinical trials and partnerships with larger pharmaceutical entities, reflecting its potential to impact the future landscapes of disease prevention and treatment. This positions CureVac as a key player within the mRNA research community and the broader field of precision medicine.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

825

Website:

https://www.curevac.com

CVAC

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

CureVac NV

About

CureVac NV

CVAC

Frequently asked questions

Is CureVac NV CVAC stock halal to invest in?

How often is CureVac NV CVAC reviewed for Shariah compliance?

Does CureVac NV CVAC pass the AAOIFI Non Permissible Income criteria?

Does CureVac NV CVAC pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy CureVac NV CVAC stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.